Market Closed -
Other stock markets
|
After market 05:32:16 pm | |||
22.39 USD | -0.62% |
|
22.46 | +0.29% |
Business description: Pfizer, Inc.
- primary care products (47.4%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (26.2%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (24.5%);
- other (1.9%).
The United States accounts for 60.8% of net sales.
Number of employees: 81,000
Sales by Activity: Pfizer, Inc.
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Global Biopharmaceuticals Business (Biopharma) | 41.91B | 79.56B | 98.99B | 57.19B | 62.4B |
Pfizer Centreone (pc1) | - | - | - | - | 1.15B |
Pfizer Ignite | - | - | - | - | 82M |
Other business activities | - | 1.73B | 1.34B | 1.31B | - |
Geographical breakdown of sales: Pfizer, Inc.
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
United States | 21.71B | 29.75B | 42.47B | 27.09B | 38.69B |
Developed Markets | - | - | - | - | 16.06B |
Emerging Markets | 8.37B | 20.7B | 20.1B | 12B | 8.88B |
Developed Europe | 7.79B | 18.34B | 21.98B | 11.65B | - |
International | 4.04B | 12.51B | 15.78B | 7.76B | - |
Executive Committee: Pfizer, Inc.
Manager | Title | Age | Since |
---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 63 | 2018-12-31 |
David Denton
DFI | Director of Finance/CFO | 60 | 2022-05-01 |
Chris Boshoff
CTO | Chief Tech/Sci/R&D Officer | - | 2024-12-31 |
Maria Rivas
CTO | Chief Tech/Sci/R&D Officer | 61 | 2022-08-31 |
Rady Johnson
CMP | Compliance Officer | 64 | 2013-11-30 |
Composition of the Board of Directors: Pfizer, Inc.
Director | Title | Age | Since |
---|---|---|---|
Suzanne Johnson
BRD | Director/Board Member | 67 | 2007-08-31 |
Helen Hobbs
BRD | Director/Board Member | 72 | 2011-12-11 |
Shantanu Narayen
BRD | Director/Board Member | 61 | 2013-09-26 |
Albert Bourla
CHM | Chairman | 63 | 2019-12-31 |
Jim Smith
BRD | Director/Board Member | 65 | 2014-06-25 |
Director/Board Member | 67 | 2015-06-24 | |
Ronald Blaylock
BRD | Director/Board Member | 65 | 2017-02-22 |
Dan Littman
BRD | Director/Board Member | 72 | 2018-03-04 |
Scott Gottlieb
BRD | Director/Board Member | 52 | 2019-06-26 |
James Quincey
BRD | Director/Board Member | 60 | 2020-02-26 |
Holdings: Pfizer, Inc.
Name | Equities | % | Valuation |
---|---|---|---|
PFIZER LIMITED 63.92% | 29,243,042 | 63.92% | 1,369,887,086 $ |
BIONTECH SE 1.54% | 3,658,361 | 1.54% | 333,130,353 $ |
CSTONE PHARMACEUTICALS 9.03% | 115,928,803 | 9.03% | 49,319,591 $ |
ALLOGENE THERAPEUTICS, INC. 10.14% | 22,032,040 | 10.14% | 32,166,778 $ |
VALNEVA 5.88% | 9,549,761 | 5.88% | 31,854,756 $ |
5,376,344 | 7.57% | 30,000,000 $ | |
ARVINAS, INC. 5.03% | 3,457,815 | 5.03% | 24,273,861 $ |
AKERO THERAPEUTICS, INC. 0.75% | 562,626 | 0.75% | 22,775,100 $ |
AKERO THERAPEUTICS, INC. 4.96% | 1,272,214 | 4.96% | 19,350,375 $ |
WAVE LIFE SCIENCES LTD. 1.23% | 1,875,000 | 1.23% | 15,150,000 $ |
Company details: Pfizer, Inc.

Group companies: Pfizer, Inc.
Name | Category and Sector |
---|---|
Pfizer Export Co.
![]() Pfizer Export Co. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Export Co. is an Irish company located in Cork. The firm develops and manufactures pharmaceutical products. |
Pharmaceuticals: Major
|
Pharmaceuticals: Major
| |
Pfizer Italia Srl
![]() Pfizer Italia Srl Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Italia Srl is a pharmaceutical company based in Latina, Italy. The Italian company manufactures pharmaceutical products. The company was founded in 1955. The CEO is Paivi Kerkola. |
Pharmaceuticals: Major
|
Viatris Netherlands BV
![]() Viatris Netherlands BV Medical DistributorsDistribution Services Part of Viatris, Inc., Viatris Netherlands BV is a Dutch company that wholesales pharmaceutical, cosmetics, and perfumes and functions as a financial holding company. The company is located in the Netherlands. |
Medical Distributors
|
Pfizer Overseas LLC |
Other Pharmaceuticals
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-0.62% | +1.22% | -14.74% | -54.41% | 128B | ||
+0.23% | +9.95% | +13.41% | +186.39% | 743B | ||
-1.50% | +0.66% | +4.20% | -15.26% | 380B | ||
+1.88% | -1.14% | +5.46% | +11.69% | 307B | ||
+4.85% | -6.18% | -53.28% | +6.08% | 266B | ||
+1.30% | +2.54% | +14.30% | -29.54% | 251B | ||
+0.24% | +2.43% | +4.05% | +5.40% | 212B | ||
+2.19% | +0.41% | -7.89% | -1.35% | 210B | ||
-0.29% | -0.54% | -37.97% | -8.69% | 199B | ||
-0.18% | -5.45% | +2.20% | +8.78% | 150B | ||
Average | +0.97% | -0.38% | -7.03% | +10.91% | 284.65B | |
Weighted average by Cap. | +0.91% | +1.50% | -2.55% | +43.56% |
Sector

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- PFE Stock
- Company Pfizer, Inc.